Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants | NEJM
Correspondence from The New England Journal of Medicine — Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants
Related Articles
Highlights from the 2021 childhood National Immunization Coverage Survey (cNICS) – Canada.ca
The 2021 cNICS measures the proportion of children who have received all routine vaccinations recommended by the National Advisory Committee on Immunization by the age…
Diagnosis and Treatment of Cellulitis
This narrative review summarizes published evidence about the epidemiology, diagnosis, and treatment of cellulitis.
Home – St. Joseph’s Healthcare Hamilton
St. Joseph’s Healthcare Hamilton – home to the renowned Firestone Institute for Respiratory Health, the Brain Body Institute and the Centre for Minimal Access Surgery…
Health Care Options – St. Joseph’s Healthcare Hamilton
Staff and physicians at St. Joseph’s Healthcare Hamilton (SJHH), Hamilton Health Sciences (HHS) and Hamilton Family Medicine (HFAM) want to ensure everyone in our community…
Health Canada authorizes updated Novavax COVID-19 vaccine targeting XBB variant | CityNews Toronto
OTTAWA — Health Canada has authorized an updated COVID-19 vaccine from Novavax that targets the XBB.1.5 variant. The new vaccine is called Nuvaxovid and is…
Dr. Vivien Brown: Protecting against HPV
Dr. Vivien Brown explains what the human papillomavirus (HPV) is, how it is transmitted, what it can lead to (i.e. genital warts and the types…
Dr. Vivien Brown: Protecting against HPV
Dr. Vivien Brown explains what the human papillomavirus (HPV) is, how it is transmitted, what it can lead to (i.e. genital warts and the types…
2 Outaouais residents contract measles, spend time in Ottawa hospital | CBC News
Western Quebec’s health authority says two people who contracted measles abroad recently spent time in a hospital in Ottawa.
Valley fever is on the rise in the U.S., and climate change could be helping the fungus spread
More than 500,000 Americans could be sickened annually by the fungus that causes Valley fever.
